Header Logo

Connection

Omid Khorram to Leiomyoma

Back to Details
This is a "connection" page, showing publications Omid Khorram has written about Leiomyoma.
Omid Khorram
Connection Strength
19.007
Leiomyoma
  1. The Roles of Non-Coding RNAs in the Pathogenesis of Uterine Fibroids. Cells. 2025 Aug 20; 14(16).
    View in: PubMed
    Score: 0.893
  2. Comparative Analysis of Differentially Expressed Long Non-Coding RNA in Pre- and Postmenopausal Fibroids. Int J Mol Sci. 2025 Jul 16; 26(14).
    View in: PubMed
    Score: 0.887
  3. Differential Expression of Small Non-Coding RNAs in Uterine Leiomyomas. Int J Mol Sci. 2025 Feb 16; 26(4).
    View in: PubMed
    Score: 0.862
  4. The in?vivo effects of knockdown of long non-coding RNA XIST on fibroid growth and gene expression. FASEB J. 2024 Nov 15; 38(21):e70140.
    View in: PubMed
    Score: 0.847
  5. The Functional Role of the Long Non-Coding RNA LINCMD1 in Leiomyoma Pathogenesis. Int J Mol Sci. 2024 Oct 27; 25(21).
    View in: PubMed
    Score: 0.844
  6. The immune landscape of uterine fibroids as determined by mass cytometry. F S Sci. 2024 Aug; 5(3):272-282.
    View in: PubMed
    Score: 0.824
  7. In Vivo Effects of Bay 11-7082 on Fibroid Growth and Gene Expression: A Preclinical Study. Cells. 2024 Jun 24; 13(13).
    View in: PubMed
    Score: 0.824
  8. Targeting the long non-coding RNA MIAT for the treatment of fibroids in an animal model. Clin Sci (Lond). 2024 Jun 19; 138(12):699-709.
    View in: PubMed
    Score: 0.823
  9. The Effect of Race/Ethnicity and MED12 Mutation on the Expression of Long Non-Coding RNAs in Uterine Leiomyoma and Myometrium. Int J Mol Sci. 2024 Jan 21; 25(2).
    View in: PubMed
    Score: 0.800
  10. Therapeutic effects of in?vivo administration of an inhibitor of tryptophan 2,3-dioxygenase (680c91) for the treatment of fibroids: a preclinical study. Fertil Steril. 2024 Apr; 121(4):669-678.
    View in: PubMed
    Score: 0.794
  11. The Influence of Race/Ethnicity on the Transcriptomic Landscape of Uterine Fibroids. Int J Mol Sci. 2023 Aug 30; 24(17).
    View in: PubMed
    Score: 0.779
  12. Therapeutic Effects of Long-Term Administration of Tranilast in an Animal Model for the Treatment of Fibroids. Int J Mol Sci. 2023 Jun 21; 24(13).
    View in: PubMed
    Score: 0.768
  13. Differential Expression of MED12-Associated Coding RNA Transcripts in Uterine Leiomyomas. Int J Mol Sci. 2023 Feb 13; 24(4).
    View in: PubMed
    Score: 0.750
  14. Differential Expression of Super-Enhancer-Associated Long Non-coding RNAs in Uterine Leiomyomas. Reprod Sci. 2022 10; 29(10):2960-2976.
    View in: PubMed
    Score: 0.714
  15. Further characterization of tryptophan metabolism and its dysregulation in fibroids. F S Sci. 2022 11; 3(4):392-400.
    View in: PubMed
    Score: 0.710
  16. Long Noncoding RNA MIAT Modulates the Extracellular Matrix Deposition in Leiomyomas by Sponging MiR-29 Family. Endocrinology. 2021 11 01; 162(11).
    View in: PubMed
    Score: 0.686
  17. Fibroid stiffness: a cellular modulator of progesterone receptor signaling. Fertil Steril. 2021 07; 116(1):91.
    View in: PubMed
    Score: 0.670
  18. Tryptophan catabolism is dysregulated in leiomyomas. Fertil Steril. 2021 10; 116(4):1160-1171.
    View in: PubMed
    Score: 0.667
  19. Functional role of the long noncoding RNA X-inactive specific transcript in leiomyoma pathogenesis. Fertil Steril. 2021 01; 115(1):238-247.
    View in: PubMed
    Score: 0.638
  20. Tranilast induces MiR-200c expression through blockade of RelA/p65 activity in leiomyoma smooth muscle cells. Fertil Steril. 2020 06; 113(6):1308-1318.
    View in: PubMed
    Score: 0.613
  21. Cross-talk between miR-29c and transforming growth factor-ß3 is mediated by an epigenetic mechanism in leiomyoma. Fertil Steril. 2019 12; 112(6):1180-1189.
    View in: PubMed
    Score: 0.601
  22. Next-generation sequencing reveals differentially expressed small noncoding RNAs in uterine leiomyoma. Fertil Steril. 2018 05; 109(5):919-929.
    View in: PubMed
    Score: 0.538
  23. Regulation of Cell Cycle Regulatory Proteins by MicroRNAs in Uterine Leiomyoma. Reprod Sci. 2019 02; 26(2):250-258.
    View in: PubMed
    Score: 0.536
  24. Expression Profiling of lncRNAs, miRNAs, and mRNAs and Their Differential Expression in Leiomyoma Using Next-Generation RNA Sequencing. Reprod Sci. 2018 02; 25(2):246-255.
    View in: PubMed
    Score: 0.506
  25. Tranilast Inhibits Genes Functionally Involved in Cell Proliferation, Fibrosis, and Epigenetic Regulation and Epigenetically Induces miR-29c Expression in Leiomyoma Cells. Reprod Sci. 2017 09; 24(9):1253-1263.
    View in: PubMed
    Score: 0.490
  26. Mechanisms underlying aberrant expression of miR-29c in uterine leiomyoma. Fertil Steril. 2016 Jan; 105(1):236-45.e1.
    View in: PubMed
    Score: 0.451
  27. miR-200c regulates IL8 expression by targeting IKBKB: a potential mediator of inflammation in leiomyoma pathogenesis. PLoS One. 2014; 9(4):e95370.
    View in: PubMed
    Score: 0.407
  28. Uterine and ovarian aryl hydrocarbon receptor (AHR) and aryl hydrocarbon receptor nuclear translocator (ARNT) mRNA expression in benign and malignant gynaecological conditions. Mol Hum Reprod. 2002 Jan; 8(1):75-80.
    View in: PubMed
    Score: 0.043
  29. Human uterine and ovarian expression of growth hormone-releasing hormone messenger RNA in benign and malignant gynecologic conditions. Fertil Steril. 2001 Jan; 75(1):174-9.
    View in: PubMed
    Score: 0.040
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.